Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Merck KGaA claims new Na+/H+-exchange inhibitors

Sep. 24, 1997

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Dual IL-6/NO production inhibitors prepared at Takeda

Sep. 19, 1997

Dual ACE/NEP inhibitors described by Zambon

Sep. 18, 1997

KRN-4884 active in several preclinical models of hypertension

Sep. 18, 1997

Biovail licenses diltiazem for Scandinavian market

Sep. 17, 1997

A-127722.5, a selective, orally active ETA antagonist for restenosis

Sep. 17, 1997

Natrecor in CHF: phase III results

Sep. 16, 1997

Results with PLC Systems' TMR System reported

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026